A detailed history of Cresset Asset Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 440,552 shares of MRK stock, worth $43.3 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
440,552
Previous 455,521 3.29%
Holding current value
$43.3 Million
Previous $56.4 Million 11.29%
% of portfolio
0.2%
Previous 0.24%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $1.66 Million - $1.93 Million
-14,969 Reduced 3.29%
440,552 $50 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $6.04 Million - $6.49 Million
48,796 Added 12.0%
455,521 $56.4 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $4.54 Million - $5.3 Million
40,134 Added 10.95%
406,725 $53.7 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $90,763 - $98,772
-906 Reduced 0.25%
366,591 $40 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $954,140 - $1.06 Million
9,268 Added 2.59%
367,497 $37.8 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $28.6 Million - $31.2 Million
263,179 Added 276.88%
358,229 $41.3 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $10.7 Million - $12 Million
-104,106 Reduced 52.27%
95,050 $10.1 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $731,697 - $938,136
-8,368 Reduced 4.03%
199,156 $22.1 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $169,567 - $190,489
-2,006 Reduced 0.96%
207,524 $18 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $177,249 - $200,920
2,123 Added 1.02%
209,530 $19.1 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $217,810 - $244,151
-2,963 Reduced 1.41%
207,407 $17.1 Million
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $565,446 - $708,294
7,823 Added 3.86%
210,370 $16.3 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $193,751 - $213,077
2,703 Added 1.35%
202,547 $15.3 Million
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $575,417 - $636,469
8,184 Added 4.27%
199,844 $15.7 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $61,216 - $72,106
889 Added 0.47%
191,660 $14.9 Million
Q4 2020

Feb 11, 2021

SELL
$71.77 - $79.65 $2.15 Million - $2.39 Million
-30,011 Reduced 13.59%
190,771 $15.7 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $214,344 - $242,960
2,929 Added 1.34%
220,782 $18.4 Million
Q2 2020

Aug 04, 2020

BUY
$70.42 - $80.13 $2.47 Million - $2.81 Million
35,092 Added 19.2%
217,853 $17 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $964,465 - $1.34 Million
15,222 Added 9.09%
182,761 $14.2 Million
Q4 2019

Feb 10, 2020

BUY
$77.58 - $87.54 $433,051 - $488,648
5,582 Added 3.45%
167,539 $15.3 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $762,397 - $831,041
10,021 Added 6.6%
161,957 $13.7 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $614,941 - $718,399
8,805 Added 6.15%
151,936 $12.8 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $2.85 Million - $3.25 Million
40,970 Added 40.1%
143,131 $12 Million
Q4 2018

May 21, 2019

BUY
$65.24 - $75.71 $6.66 Million - $7.73 Million
102,161 New
102,161 $7.86 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.